In this week’s episode, Dr. Shanmugam welcomes Dr. Mary Beth Son, the senior author and corresponding author of “Treatment of Multisystem Inflammatory Syndrome in Children: Understanding Differences in Results of Comparative Effectiveness Studies.” This study sought to determine whether the application of different MIS-C definitions and differing disease severity in patients participating in two separate comparative cohorts underlay discrepant results. Dr. Jon Hausmann, pediatric rheumatologist and host of “ACR on Air”, joins Dr. Shanmugam and Dr. Son to add to the significant expertise on this episode, with his own in both clinical pediatric and adult rheumatology. Here, Dr. Hausmann shares further insights on integrating the published literature with pediatric treatment of MIS-C.
Flere episoder fra "ACR Journals On Air"
Less is More
39:07Caring for older adults who suffer from rheumatic disease comes with it the need to manage multimorbidity, polypharmacy, and geriatric syndromes. Often, shifting priorities for those suffering with rheumatic musculoskeletal diseases (RMDs) is needed, sometimes leading to a prescribing cascade. The practice of ‘deprescribing’, an approach to optimize medication use to deliver a more ‘goal-concordant’ type of care was the focus of Dr. Una Makris and Dr. Jiha Lee’s latest research: “Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be More“ When caring for older adults with RMDs, it very well may be, that “Less is More”.
Location, Location, Location
39:54In a study recently published in “ACR Open Rheumatology” titled: “Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States“, first author Dr. Sharon Dowell set out to understand some of the factors associated with regional variation of rheumatoid arthritis in the United States. Sharon Dowell, MD presents her study’s findings and conclusions. ACR’s RISE Team member, Tracy Johansson, MS, joins us as well to discuss how RISE attempts to close these gaps. Together, both of our guests help us to understand how geographic location contributes to a disproportionate level of care for those with RA and what we can do about it.
Gå ikke glip af nogen episoder af “ACR Journals On Air” - abonnér på podcasten med gratisapp GetPodcast.
SSc Pulmonary Hypertension
32:10Pulmonary hypertension (PH), being a serious complication of systemic sclerosis (SSc), develops late in the course of SSc and carries with it a poor prognosis. With the median survival of about 3 years, new evidence suggests that early diagnosis and treatment can significantly improve survival. Joining us this week is Christopher P Denton PhD FRCP, senior author of “Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis,” published in Arthritis and Rheumatology. Dr. Denton’s latest study explores “the prediction of short-term risk for PH using serial pulmonary function tests (PFTs)”
Uric Acid: How Low Can You Go
20:13Dr. Joshua Baker, first author of a paper recently published in “Arthritis & Rheumatology”, “Associations Between Low Serum Urate, Body Composition, and Mortality“, is our guest today. Dr. Baker, recognizing the controversy in whether low serum urate or uric acid (UA) level contribute to adverse outcomes, set out to evaluate the relation between low serum UA levels and sarcopenia, to assess whether sarcopenia confounds associations between these low levels and mortality.
37:13When rheumatology concepts battle it out in a team bracket tournament, you get “Rheum Madness”! “A place for everyone who is crazy about rheumatology to connect, collaborate and compete” in an online, learning experience, created by Dr. David Leverenz. His body of work, “Rheum Madness: Creating an Online Community of Inquiry”, featured in this episode, analyzes participant engagement and the presence of the online community of inquiry within its first year. Dr. Leverenz is an educator and rheumatologist at Duke University. He has a growing body of work in Medical Education. He recently completed a Clinician Scholar Educator award from the Rheumatology Research Foundation to create “Rheum Madness”
Partnering For New Models of OA Care
33:19Osteoarthritis is incredibly common, affecting more than 500 million people across the globe. It is a significant cause of pain and disability and carries high healthcare costs and societal burdens. Around the world, there are not enough rheumatology specialists to treat all the patients with OA, and in many countries, OA management is coordinated by primary care internists. However, despite good guidelines recommending first-line evidence-based treatments with muscle strengthening, physical activity, weight loss, and judicious medication management, there are many inconsistencies in OA care delivery. This week, we focus on the manuscript “Effectiveness of a New Service Delivery Model for Management of Knee Osteoarthritis in Primary Care: A Cluster Randomized Controlled Trial” and our guest is Dr. David Hunter, its first author.
A.I. Has Promise in RA
29:18In this week’s episode, we’ll be looking at a paper recently published in “ACR Open Rheumatology” titled: “Machine Learning Applied to Patient-Reported Outcomes to Classify Physician-Derived Measures of Rheumatoid Arthritis Disease Activity“. This study used machine learning tools to investigate whether longitudinal patient-reported outcome data can be a proxy for Clinical Disease Activity Index (CDAI), presenting interesting findings that may impact the practice of rheumatology. Our guest this week is the paper’s first author, Dr. Jeffrey Curtis. Dr. Curtis is the Marguerite Jones Harbert – Gene V. Ball Endowed Professor in Rheumatology and Immunology at the University of Alabama at Birmingham. He has many accolades to his name, including being a prior winner of the Henry Kunkel Young Investigator Award and being a member of the American Society for Clinical Investigation.
Supporting International Graduates in Rheumatology
34:10This week, we welcome Dr. Ruth Fernandez Ruiz to our show, a physician-scientist and Assistant Professor of Medicine at Weill Cornell Medical College and Hospital for Special Surgery in New York City. Dr. Fernandez Ruiz’s award-winning work focuses on the interplay of genetic variation, type I interferons, and immune dysregulation in lupus. However, her latest study published in “Arthritis & Rheumatology” entitled: Supporting International Medical Graduates in Rheumatology: A Call to Action seeks to understand and draw attention to the challenges and barriers that prevent international medical graduates from coming to the U.S. and practicing medicine in the field of rheumatology.
Sleep Disorders Among Patients with Rheumatoid Arthritis
23:44Dr. Patricia Katz is our guest this week as she presents her latest study “Sleep Disorders among Individuals with Rheumatoid Arthritis”, recently published in “Arthritis Care & Research”. This study focuses on patients with RA who self-report common sleep problems such as obstructive sleep apnea, restless leg syndrome and short sleep and examines the prevalence of these disorders plus their potential negative health implications. Dr. Katz shares with us her methods, findings and conclusions as well as some career advice on writing an academic paper, what she finds most challenging about it, and what the editorial process looks like for “ACR Open Rheumatology” and what they look for while reviewing and editing manuscripts.
The TULIP Study, Three Years On
25:02In this episode, Dr. Shanmugam discusses “A Randomized, Placebo-controlled Phase 3 Extension Trial of Long-term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus”, a three-year long-term study designed to understand the safety of anifrolumab in patients with systemic lupus erythematosus (SLE). This study, which was recently published in “Arthritis & Rheumatology”, represents the longest placebo-controlled clinical trial performed in SLE to date. She is joined by our guest, Dr. Richard Furie, Chief of the Division of Rheumatology at Northwell Health in New York and co-author of the paper.